Expanded Access Protocol for PV-10 for Cutaneous or Subcutaneous Tumors

Summary

This compassionate use protocol provides expanded access for investigational use of PV-10 in cancer patients who are not eligible for an existing PV-10 clinical trial, for whom there is no comparable or satisfactory approved alternative therapy and whom, in the opinion of the investigator, may benefit from PV-10 administration.

Timeline

Start

—

Primary completion

—

Completion

—

Drugs

Indications